Cargando…

End-of-life care of patients with idiopathic pulmonary fibrosis

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a progressive disease with median survival from 2 to 7 years. Palliative care is an important part of patients´ care as lung transplantation is not an option for the majority of patients. The aim of this study was to describe treatment practices, de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rajala, Kaisa, Lehto, Juho T., Saarinen, M., Sutinen, E., Saarto, T., Myllärniemi, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5059981/ https://www.ncbi.nlm.nih.gov/pubmed/27729035 http://dx.doi.org/10.1186/s12904-016-0158-8

Ejemplares similares

mMRC dyspnoea scale indicates impaired quality of life and increased pain in patients with idiopathic pulmonary fibrosis
por: Rajala, Kaisa, et al.
Publicado: (2017)

Marked deterioration in the quality of life of patients with idiopathic pulmonary fibrosis during the last two years of life
por: Rajala, K., et al.
Publicado: (2018)

Factor analysis identifies three separate symptom clusters in idiopathic pulmonary fibrosis
por: Seppälä, Severi, et al.
Publicado: (2020)

KIF15 missense variant is associated with the early onset of idiopathic pulmonary fibrosis
por: Hollmén, Maria, et al.
Publicado: (2023)

Label-free plasma proteomics identifies haptoglobin-related protein as candidate marker of idiopathic pulmonary fibrosis and dysregulation of complement and oxidative pathways
por: Saraswat, Mayank, et al.
Publicado: (2020)

End-of-life care for idiopathic pulmonary fibrosis patients with acute exacerbation
por: Akiyama, Norimichi, et al.
Publicado: (2022)

Palliative care and end of life management in patients with idiopathic pulmonary fibrosis
por: Micco, Assunta, et al.
Publicado: (2023)

Re-evaluation of diagnostic parameters is crucial for obtaining accurate data on idiopathic pulmonary fibrosis
por: Kaunisto, Jaana, et al.
Publicado: (2015)

Hemoglobin α and β are ubiquitous in the human lung, decline in idiopathic pulmonary fibrosis but not in COPD
por: Ishikawa, Nobuhisa, et al.
Publicado: (2010)

Gremlin-1 Overexpression in Mouse Lung Reduces Silica-Induced Lymphocyte Recruitment – A Link to Idiopathic Pulmonary Fibrosis through Negative Correlation with CXCL10 Chemokine
por: Koli, Katri, et al.
Publicado: (2016)

Pharmacological treatment of idiopathic pulmonary fibrosis – preclinical and clinical studies of pirfenidone, nintedanib, and N-acetylcysteine
por: Myllärniemi, Marjukka, et al.
Publicado: (2015)

Demographics and survival of patients with idiopathic pulmonary fibrosis in the FinnishIPF registry
por: Kaunisto, Jaana, et al.
Publicado: (2019)

The required competencies of physicians within palliative care from the perspectives of multi-professional expert groups: a qualitative study
por: Melender, Hanna-Leena, et al.
Publicado: (2020)

Idiopathic pulmonary fibrosis - a systematic review on methodology for the collection of epidemiological data
por: Kaunisto, Jaana, et al.
Publicado: (2013)

Delay and inequalities in the treatment of idiopathic pulmonary fibrosis: the case of two Nordic countries
por: Pesonen, Ida, et al.
Publicado: (2018)

Upregulation of activin-B and follistatin in pulmonary fibrosis – a translational study using human biopsies and a specific inhibitor in mouse fibrosis models
por: Myllärniemi, Marjukka, et al.
Publicado: (2014)

Overall drug treatment of idiopathic pulmonary fibrosis patients from national registries – a real-world study from Finland
por: Kaunisto, Jaana, et al.
Publicado: (2023)

Organisation of diagnosis and treatment of idiopathic pulmonary fibrosis and other interstitial lung diseases in the Nordic countries
por: Bendstrup, Elisabeth, et al.
Publicado: (2015)

Are physicians in primary health care able to recognize pulmonary fibrosis?
por: Purokivi, Minna, et al.
Publicado: (2017)

Transforming Growth Factor Beta 1 Activation, Storage, and Signaling Pathways in Idiopathic Pulmonary Fibrosis in Dogs
por: Krafft, E., et al.
Publicado: (2014)

Leveraging global multi-ancestry meta-analysis in the study of idiopathic pulmonary fibrosis genetics
por: Partanen, Juulia J., et al.
Publicado: (2022)

Undergraduate curriculum in palliative medicine at Tampere University increases students’ knowledge
por: Lehto, Juho T., et al.
Publicado: (2017)

Clinical Profile of Patients with Idiopathic Pulmonary Fibrosis in Real Life
por: Morena, Diego, et al.
Publicado: (2023)

Idiopathic pulmonary fibrosis management: caring is sparing
por: Nava, Stefano, et al.
Publicado: (2020)

Hospitalizations in patients with idiopathic pulmonary fibrosis
por: Kim, Hyun J., et al.
Publicado: (2021)

Assessing quality of life of idiopathic pulmonary fibrosis patients: the INSTAGE study
por: Suarez-Cuartin, Guillermo, et al.
Publicado: (2019)

Idiopathic pulmonary fibrosis
por: Meltzer, Eric B, et al.
Publicado: (2008)

Idiopathic Pulmonary Fibrosis
por: Lynch, Joseph P., et al.
Publicado: (2011)

Management of Idiopathic Pulmonary Fibrosis
por: Pleasants, Roy, et al.
Publicado: (2019)

The treatment of idiopathic pulmonary fibrosis
por: Woodcock, Hannah V., et al.
Publicado: (2014)

The impact of the duration of the palliative care period on cancer patients with regard to the use of hospital services and the place of death: a retrospective cohort study
por: Hirvonen, Outi M., et al.
Publicado: (2020)

Survival and end-of-life aspects among subjects on long-term noninvasive ventilation
por: Rantala, Heidi A., et al.
Publicado: (2020)

Cough in Idiopathic Pulmonary Fibrosis
por: Mann, Jennifer, et al.
Publicado: (2021)

The Management of Patients With Idiopathic Pulmonary Fibrosis
por: Spagnolo, Paolo, et al.
Publicado: (2018)

Patient Registries in Idiopathic Pulmonary Fibrosis
por: Culver, Daniel A., et al.
Publicado: (2019)

Effect of palliative care decisions making on hospital service use at end-of-life in patients with malignant brain tumors: a retrospective study
por: Nåhls, Nelli-Sofia, et al.
Publicado: (2023)

Perceptions of fatigue in patients with idiopathic pulmonary fibrosis or sarcoidosis
por: Bloem, Ada E. M., et al.
Publicado: (2021)

Beyond standard care?—idiopathic pulmonary fibrosis patients’ perception of care coordinators
por: Hagmeyer, Lars, et al.
Publicado: (2020)

Mycobacterial Pulmonary Infections in Patients with Idiopathic Pulmonary Fibrosis
por: Park, Sung-Woo, et al.
Publicado: (2012)

The Efficacy of Pulmonary Rehabilitation in Patients with Idiopathic Pulmonary Fibrosis
por: Choi, Hee Eun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_96ttp95kdmvhefjru5up6uo0lo